Martin Simonetti

Martin Simonetti is currently the CEO of PBS Biotech, a scientific equipment company, since 2025. Prior to this, he spent twelve years advising small and mid-sized biotechnology companies. He previously served as President and CEO of VLST (2005–2013), and held senior leadership roles at Dendreon, including CFO, SVP of Finance, and Treasurer. Earlier, he was VP of Operations and Finance at Amgen BioPharma and Director of Amgen’s Colorado Operations. His career began at Genentech, where he worked as a scientist in Medicinal and Analytical Chemistry before transitioning to finance roles as a financial analyst and group controller.

Mr. Simonetti currently serves on the Boards of Curtana Pharmaceuticals and Eisana. His past board service includes Alexandria Real Estate Equities (NYSE: ARE), Icagen (acquired by Pfizer), and Life Sciences Washington (as Chairman). He was also a member of the Dean’s Executive Advisory Board at Seattle University’s Albers School of Business and Economics.

He holds an M.S. and B.S. from the University of California, Davis, and an M.B.A. from the University of Santa Clara.